Evaluation of an oligonucleotide ligation assay for detection of mutations in HIV-1 subtype C individuals who have high level resistance to nucleoside reverse transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors

Journal of Virological Methods

Volumn 125, Issue 2, 2005, Pages 99-109

  Wallis, Carole Lorraine ^a   Mahomed, Imraan ^a   Morris, Lynn ^b   Chidarikire, Thato ^b   Stevens, Gwynn ^b   Rekhviashvili, Natela ^b   Stevens, Wendy ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

Drug resistance; HIV 1; OLA; Subtype C

Indexed keywords

RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; CODON; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; OLIGONUCLEOTIDE LIGATION ASSAY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTYPE; VIRUS MUTATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 15544372783     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2005.01.004     Document Type: Article

References (11)

1. J.D. Baxter, D.L. Mayers, D.N. Wentworth, J.D. Neaton, M.L. Hoover, M.A. Winters, S.B. Mannheimer, M.A. Thompson, D.I. Abrams, B.J. Brizz, J.P. Iaonnidis, and T.C. Merigan A randomised study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS AIDS 14 9 2000 F83 F93
2. I. Beck, M. Madhumita, G. Pepper, A. Wright, S. Hamilton, E. Langston, and L. Frenkel Rapid and sensitive oligonucleotide ligation assay for detection of mutations in the human immunodeficiency virus type 1 associated with high level resistance to protease inhibitors J. Clin. Microbiol. April 2002 1413 1419
3. Beck I., Frenkel L., 2002. Genotyping kits for the detection of HIV-1 pol drug-resistance mutations by an oligonucleotide ligation assay. Protocol Version 1.0.
4. J. Durant, P. Clevenbergh, P. Halfon, P. Delgiudice, S. Porsin, P. Simonet, N. Montagne, C.A. Boucher, J.M. Schapira, and P. Dellamonica Drug resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial Lancet 353 9171 1999 2195 2199
5. R.E. Edelstein, D.A. Nickerson, V.O. Tobe, L.A. Manns-Arcuino, and L.M. Frenkel Oligonucleotide ligation assay for detecting mutations in the human immunodeficiency virus type 1 pol gene that are associated with resistance to Zidovudine, Didanosine and Lamivudine J. Clin. Microbiol. 36 2 1998 569 572
6. M. Samiotaki, M. Kwiatkowski, J. Parik, and U. Lamdegren Dual-colour detection of DNA sequence variants by ligase-mediated analysis. Genomics 20 2 1994 238 242
7. Y. Vega, L. Perez-Alvarez, E. Delgado, M.L. Villahermosa, M. Munoz, R. Carmona, M. Sierra, E. Vazquez de Parga, G. Casado, M. Thomson, G. Contreras, L. Medrano, and R. Najera Oligonucleotide ligation assay (OLA) for the detection and quantification of point mutations associated with resistance to antiretroviral agents in B, non-B subtypes and recombinant forms of HIV-1 The Second IAS Conference of HIV Pathogens and Treatment Paris 2003
8. National Institutes of Health (NIH) AIDS Research and Reference Reagent Program, 2005. www.aidsreagent.org
9. UNAIDS, 2004. Report on the global AIDS epidemic. http://www.unaids.org.
10. South African HIV/AIDS Statistics, 2005. http://www.avert.org/ safricastats.htm
11. South African Department of Health, 2003. http://www.doh.gov.za/aids/ index/html